OS Therapies Incorporated (OSTX)
NYSEAMERICAN: OSTX · Real-Time Price · USD
2.040
0.00 (0.00%)
Oct 10, 2025, 2:45 PM EDT - Market open

OS Therapies Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
9.353.971.131.152.66
Research & Development
5.892.843.223.292.17
Other Operating Expenses
---01.16
Total Operating Expenses
15.246.814.344.456
Operating Income
-15.24-6.81-4.34-4.45-4.84
Interest Income
0-0--
Interest Expense
-0.45-2.05-3.45-1.81-2.58
Other Non-Operating Income (Expense)
--0.02---
Total Non-Operating Income (Expense)
-0.45-2.07-3.45-1.81-2.58
Pretax Income
-15.69-8.88-7.79-6.25-7.42
Net Income
-16.25-10.89-7.92-6.38-7.51
Net Income Attributable to Preferred Dividends
-20.130.130.09
Net Income to Common
-16.25-10.89-7.92-6.38-7.51
Shares Outstanding (Basic)
2112555
Shares Outstanding (Diluted)
2112555
Shares Change (YoY)
260.78%127.97%8.80%--
EPS (Basic)
-0.74-0.88-1.46-1.28-1.50
EPS (Diluted)
-0.74-0.88-1.46-1.28-1.50
Free Cash Flow
-11.56-7.28-3.01-3.79-4.41
Free Cash Flow Per Share
-0.55-0.59-0.55-0.76-0.88
EBITDA
-15.24-5.39-1.69-3.29-2.77
EBIT
-15.24-6.81-4.34-4.45-4.84
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q